Showing results (101-110 of 385) with videos related to
Sort By:
Pageof 39
Proteomics. Clinical Applications|August 5, 2015
Multidimensional protein identification technology analysis highlights mitoxantrone-induced expression modulations in the primary prostate cancer cell proteomeJuliane Symes, Andreas Evangelou, Alex Ignatchenko, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 28, 2015
Time from first detectable PSA following radical prostatectomy to biochemical recurrence: A competing risk analysisLeonora de Boo, Melania Pintilie, Paul Yip, et al.Clinical Biochemistry|November 5, 2002
Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observationPeter S Bunting, Gerrit DeBoer, Richard Choo, et al.The Journal of Urology|January 24, 2012
The effect of radiation on semen quality and fertility in men treated with brachytherapy for early stage prostate cancerDilpreet K Singh, Karen Hersey, Nathan Perlis, et al.European Urology|November 11, 2017
The Role of Surgery in Metastatic Bladder Cancer: A Systematic ReviewMohammad Abufaraj, Guido Dalbagni, Siamak Daneshmand, et al.Urology Annals|October 1, 2010
Does nerve-sparing radical prostatectomy increase the risk of positive surgical margins and biochemical progression?Sultan Saud Alkhateeb, Shabbir M Alibhai, Antonio Finelli, et al.Urology|October 18, 2002
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trialBob Djavan, Mesut Remzi, Alexandre R Zlotta, et al.Clinical Epigenetics|March 29, 2019
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progressionShivani Kamdar, Ruth Isserlin, Theodorus Van der Kwast, et al.Journal of Clinical Pathology|June 19, 2013
Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinomaMichelle R Downes, Emina E Torlakovic, Najla Aldaoud, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 21, 2024
Using active surveillance for Gleason 7 (3+4) prostate cancer: A narrative reviewRui Bernardino, Rashid K Sayyid, Ricardo Leão, et al.Pageof 39